Chinese Pharmaceutical Industry

Table of Contents

Executive summary

Foreword - Professor Xiaoming Wu, Chancellor, China Pharmaceutical University

1.         Introduction

2.         An overview of the pharmaceutical industry in China
2.1. Economic reform and the open door policy in context
2.2. The growth of the Chinese pharmaceutical industry
2.3. The structure of the Chinese pharmaceutical industry
2.3.1. Industry output
2.3.2. Import and export
2.3.3. The industry layout
2.4. R&D in China
2.5. Marketing approvals and manufacturing
2.6. Non-Chinese investment enterprises in China

3.         Competing in the international market
3.1. Introduction
3.2. Measuring trading competitiveness
3.3. Potential trading competitiveness

4.         Business opportunities for non-Chinese pharmaceutical firms in China
4.1. Factors affecting business opportunities in China
4.1.1. Chinese Authorities' commitments and administrative measures
4.1.2. Chinese consumer demand for pharmaceutical products
4.2. The factors bringing business opportunities
4.3. How to capture business opportunities
4.4. Which would be the profitable fields for non-Chinese pharmaceutical firms?

5.         Conclusion

6.         Appendices
6.1. Case studies
6.1.1. Sino-Swed Pharmaceutical Corp.LTD (SSPC)
6.1.2. Pfizer (China) Pharmaceuticals Limited
6.2. References
6.3. Glossary
6.4. Source data
6.5. Author’s Biography